Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026)
Scholar Rock Holding's (SRRK) quarterly Amortizatization of Intangibles came in at $169000.0 in Q1 2026, down 91.13% year-on-year from $1.9 million in Q1 2025, and down 14.65% quarter-over-quarter from $198000.0 in Q4 2025.
Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $169000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 91.13% year-over-year to $169000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 57.31% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 24.61% from the prior year.
- Amortizatization of Intangibles retreated to $169000.0 in Q1 2026 per SRRK's latest filing, from $198000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.9 million in Q1 2024 and bottomed at -$152000.0 in Q2 2022.
- The 5-year median for Amortizatization of Intangibles is $1.3 million (2024), against an average of $1.0 million.
- Across the five-year window, Amortizatization of Intangibles jumped 1598.18% in 2022 and sank 91.13% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.6 million in 2022, then gained by 9.41% to $1.8 million in 2023, then dropped by 25.35% to $1.3 million in 2024, then plunged by 85.29% to $198000.0 in 2025, then decreased by 14.65% to $169000.0 in 2026.
- Per Business Quant, the three latest SRRK Amortizatization of Intangibles figures stand at $169000.0 (Q1 2026), $198000.0 (Q4 2025), and $495000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Scholar Rock Holding | 6.32 Bn | 6.32 Bn | - | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Dec 31, 2025 | 198,000.00 |
| Dec 31, 2025 | 198,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 709,000.00 |
| Sep 30, 2024 | 709,000.00 |
| Jun 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Dec 31, 2023 | 1.80 Mn |